Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan

PURPOSE: Ocular vascular diseases are common causes of visual impairment and blindness, for which anti-vascular endothelial growth factor (anti-VEGF) is the first-line therapy. Current study describes the profile of patients receiving intravitreal anti-VEGF injections (IVI), and gender variation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Bhim Bahadur, Rai, Deepa, Maddess, Ted
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243486/
https://www.ncbi.nlm.nih.gov/pubmed/37288001
http://dx.doi.org/10.2147/OPTH.S414621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243486/
https://www.ncbi.nlm.nih.gov/pubmed/37288001
http://dx.doi.org/10.2147/OPTH.S414621

Ejemplares similares